{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:18:16Z","timestamp":1766758696900,"version":"3.48.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"DOI":"10.7759\/cureus.100123","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:15:39Z","timestamp":1766758539000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Nitisinone on Aortic Stenosis Disease Progression in Patients With Alkaptonuria: An Analysis of the Suitability of Nitisinone in Alkaptonuria (SONIA) 2 Study"],"prefix":"10.7759","author":[{"given":"Callum","family":"Bruce","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Priyanka","family":"Meenamkuzhy-Hariharan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahdat","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Eleuteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lakshminarayan","family":"Ranganath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Imrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Baptiste","family":"Arnoux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitta","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattias","family":"Rudebeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)41972-6","article-title":"The incidence of alkaptonuria: a study in chemical individuality","volume":"160","author":"Garrod AE","year":"1902","unstructured":"Garrod AE. The incidence of alkaptonuria: a study in chemical individuality. Lancet. 1902, 160:1616-20. 10.1016\/S0140-6736(01)41972-6","journal-title":"Lancet"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2021.05.007","article-title":"Evaluating the aortic stenosis phenotype before and after the effect of homogentisic acid lowering therapy: Analysis of a large cohort of eighty-one alkaptonuria patients","volume":"133","author":"Ranganath LR","year":"2021","unstructured":"Ranganath LR, Heseltine T, Khedr M, Fisher MF. Evaluating the aortic stenosis phenotype before and after the effect of homogentisic acid lowering therapy: Analysis of a large cohort of eighty-one alkaptonuria patients. Mol Genet Metab. 2021, 133:324-31. 10.1016\/j.ymgme.2021.05.007","journal-title":"Mol Genet Metab"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa021736","article-title":"Natural history of alkaptonuria","volume":"347","author":"Phornphutkul C","year":"2002","unstructured":"Phornphutkul C, Introne WJ, Perry MB, et al.. Natural history of alkaptonuria. N Engl J Med. 2002, 347:2111-21. 10.1056\/NEJMoa021736","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"crossref","DOI":"10.1016\/0002-9343(63)90089-5","article-title":"Biochemical, pathologic and clinical aspects of alkaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584-1962)","volume":"34","author":"O'Brien WM","year":"1963","unstructured":"O'Brien WM, La Du BN, Bunim JJ. Biochemical, pathologic and clinical aspects of alkaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584-1962). Am J Med. 1963, 34:813-38.","journal-title":"Am J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-3-9302","article-title":"Ochronosis as an unusual cause of valvular defect: a case report","volume":"3","author":"Wilke A","year":"2009","unstructured":"Wilke A, Steverding D. Ochronosis as an unusual cause of valvular defect: a case report. J Med Case Rep. 2009, 3:9302. 10.1186\/1752-1947-3-9302","journal-title":"J Med Case Rep"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/jocs.12129","article-title":"Alkaptonuria-associated aortic stenosis","volume":"28","author":"Lok ZS","year":"2013","unstructured":"Lok ZS, Goldstein J, Smith JA. Alkaptonuria-associated aortic stenosis. J Card Surg. 2013, 28:417-20. 10.1111\/jocs.12129","journal-title":"J Card Surg"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.15406\/jccr.2017.09.00336","article-title":"Black heart at surgery - primary diagnosis of alkaptonuria at surgery","volume":"9","author":"Karavaggelis A","year":"2017","unstructured":"Karavaggelis A, Young C, Attia R. Black heart at surgery - primary diagnosis of alkaptonuria at surgery. J Cardiol Curr Res. 2017, 9:00335. 10.15406\/jccr.2017.09.00336","journal-title":"J Cardiol Curr Res"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1002\/jimd.12152","article-title":"Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review","volume":"42","author":"Ranganath LR","year":"2019","unstructured":"Ranganath LR, Norman BP, Gallagher JA. Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease-A review. J Inherit Metab Dis. 2019, 42:776-92. 10.1002\/jimd.12152","journal-title":"J Inherit Metab Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.10.017","article-title":"Aortic stenosis and vascular calcifications in alkaptonuria","volume":"105","author":"Hannoush H","year":"2012","unstructured":"Hannoush H, Introne WJ, Chen MY, et al.. Aortic stenosis and vascular calcifications in alkaptonuria. Mol Genet Metab. 2012, 105:198-202. 10.1016\/j.ymgme.2011.10.017","journal-title":"Mol Genet Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9339-z","article-title":"Cardiovascular manifestations of alkaptonuria","volume":"34","author":"Pettit SJ","year":"2011","unstructured":"Pettit SJ, Fisher M, Gallagher JA, Ranganath LR. Cardiovascular manifestations of alkaptonuria. J Inherit Metab Dis. 2011, 34:1177-81. 10.1007\/s10545-011-9339-z","journal-title":"J Inherit Metab Dis"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s10545-011-9374-9","article-title":"Natural history of alkaptonuria revisited: analyses based on scoring systems","volume":"34","author":"Ranganath LR","year":"2011","unstructured":"Ranganath LR, Cox TF. Natural history of alkaptonuria revisited: analyses based on scoring systems. J Inherit Metab Dis. 2011, 34:1141-51. 10.1007\/s10545-011-9374-9","journal-title":"J Inherit Metab Dis"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1002\/jmd2.12137","article-title":"Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre","volume":"55","author":"Ranganath LR","year":"2020","unstructured":"Ranganath LR, Milan AM, Hughes AT, et al.. Reversal of ochronotic pigmentation in alkaptonuria following nitisinone therapy: Analysis of data from the United Kingdom National Alkaptonuria Centre. JIMD Rep. 2020, 55:75-87. 10.1002\/jmd2.12137","journal-title":"JIMD Rep"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(20)30228-X","article-title":"Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial","volume":"8","author":"Ranganath LR","year":"2020","unstructured":"Ranganath LR, Psarelli EE, Arnoux JB, et al.. Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial. Lancet Diabetes Endocrinol. 2020, 8:762-72. 10.1016\/S2213-8587(20)30228-X","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2011.04.016","article-title":"A 3-year randomized therapeutic trial of nitisinone in alkaptonuria","volume":"103","author":"Introne WJ","year":"2011","unstructured":"Introne WJ, Perry MB, Troendle J, et al.. A 3-year randomized therapeutic trial of nitisinone in alkaptonuria. Mol Genet Metab. 2011, 103:307-14. 10.1016\/j.ymgme.2011.04.016","journal-title":"Mol Genet Metab"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206033","article-title":"Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment","volume":"75","author":"Ranganath LR","year":"2016","unstructured":"Ranganath LR, Milan AM, Hughes AT, et al.. Suitability Of Nitisinone In Alkaptonuria 1 (SONIA 1): an international, multicentre, randomised, open-label, no-treatment controlled, parallel-group, dose-response study to investigate the effect of once daily nitisinone on 24-h urinary homogentisic acid excretion in patients with alkaptonuria after 4 weeks of treatment. Ann Rheum Dis. 2016, 75:362-7. 10.1136\/annrheumdis-2014-206033","journal-title":"Ann Rheum Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.023997","article-title":"Medical treatment of aortic stenosis","volume":"134","author":"Marquis-Gravel G","year":"2016","unstructured":"Marquis-Gravel G, Redfors B, Leon MB, G\u00e9n\u00e9reux P. Medical treatment of aortic stenosis. Circulation. 2016, 134:1766-84. 10.1161\/CIRCULATIONAHA.116.023997","journal-title":"Circulation"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1530\/ERP-20-0026","article-title":"A practical guideline for performing a comprehensive transthoracic echocardiogram in adults: the British Society of Echocardiography minimum dataset","volume":"7","author":"Robinson S","year":"2020","unstructured":"Robinson S, Rana B, Oxborough D, et al.. A practical guideline for performing a comprehensive transthoracic echocardiogram in adults: the British Society of Echocardiography minimum dataset. Echo Res Pract. 2020, 7:G59-93. 10.1530\/ERP-20-0026","journal-title":"Echo Res Pract"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1530\/ERP-20-0035","article-title":"Echocardiographic assessment of aortic stenosis: a practical guideline from the British Society of Echocardiography","volume":"8","author":"Ring L","year":"2021","unstructured":"Ring L, Shah BN, Bhattacharyya S, et al.. Echocardiographic assessment of aortic stenosis: a practical guideline from the British Society of Echocardiography. Echo Res Pract. 2021, 8:G19-59. 10.1530\/ERP-20-0035","journal-title":"Echo Res Pract"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.2008.03000.x","article-title":"Alkaptonuria--a review of surgical and autopsy pathology","volume":"53","author":"Helliwell TR","year":"2008","unstructured":"Helliwell TR, Gallagher JA, Ranganath L. Alkaptonuria--a review of surgical and autopsy pathology. Histopathology. 2008, 53:503-12. 10.1111\/j.1365-2559.2008.03000.x","journal-title":"Histopathology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.115.020194","article-title":"Mending a darkened heart: alkaptonuria discovered during aortic valve replacement","volume":"133","author":"Schuuring MJ","year":"2016","unstructured":"Schuuring MJ, Delemarre B, Keyhan-Falsafi AM, van der Bilt IA. Mending a darkened heart: alkaptonuria discovered during aortic valve replacement. Circulation. 2016, 133:e444-5. 10.1161\/CIRCULATIONAHA.115.020194","journal-title":"Circulation"},{"key":"ref21","article-title":"Cardiovascular ochronosis","volume":"111","author":"Gaines JJ Jr","year":"1987","unstructured":"Gaines JJ Jr, Pai GM. Cardiovascular ochronosis. Arch Pathol Lab Med. 1987, 111:991-4.","journal-title":"Arch Pathol Lab Med"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2020.107219","article-title":"Cardiovascular ochronosis","volume":"48","author":"Ather N","year":"2020","unstructured":"Ather N, Roberts WC. Cardiovascular ochronosis. Cardiovasc Pathol. 2020, 48:107219. 10.1016\/j.carpath.2020.107219","journal-title":"Cardiovasc Pathol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.1995.11718475","article-title":"The clinical manifestations of ochronosis: a review","volume":"50","author":"Van Offel JF","year":"1995","unstructured":"Van Offel JF, De Clerck LS, Francx LM, Stevens WJ. The clinical manifestations of ochronosis: a review. Acta Clin Belg. 1995, 50:358-62. 10.1080\/17843286.1995.11718475","journal-title":"Acta Clin Belg"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2012-302265","article-title":"The evolving epidemiology of valvular aortic stenosis. the Troms\u00f8 study","volume":"99","author":"Eveborn GW","year":"2013","unstructured":"Eveborn GW, Schirmer H, Heggelund G, Lunde P, Rasmussen K. The evolving epidemiology of valvular aortic stenosis. the Troms\u00f8 study. Heart. 2013, 99:396-400. 10.1136\/heartjnl-2012-302265","journal-title":"Heart"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.05.021","article-title":"ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons","volume":"48","author":"Bonow RO","year":"2006","unstructured":"Bonow RO, Carabello BA, Chatterjee K, et al.. ACC\/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006, 48:e1-148. 10.1016\/j.jacc.2006.05.021","journal-title":"J Am Coll Cardiol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/373834-effect-of-nitisinone-on-aortic-stenosis-disease-progression-in-patients-with-alkaptonuria-an-analysis-of-the-suitability-of-nitisinone-in-alkaptonuria-sonia-2-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:15:40Z","timestamp":1766758540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/373834-effect-of-nitisinone-on-aortic-stenosis-disease-progression-in-patients-with-alkaptonuria-an-analysis-of-the-suitability-of-nitisinone-in-alkaptonuria-sonia-2-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.100123","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}